Lv1
40 积分 2023-07-21 加入
How I approach the treatment of thrombotic complications in patients with myeloproliferative neoplasms
3天前
求助中
How I approach the treatment of thrombotic complications in patients with myeloproliferative neoplasms
3天前
已关闭
Refined ELN 2024 risk stratification improves survival prognostication following venetoclax-based therapy in AML
6天前
已关闭
Refined ELN 2024 risk stratification improves survival prognostication following venetoclax-based therapy in AML
6天前
已关闭
Refined ELN 2024 risk stratification improves survival prognostication following venetoclax-based therapy in AML
6天前
已关闭
Sex-based Differences in Risk for Therapy-related Myeloid Neoplasms
7天前
已完结
How Could We Further Improve the Gilteritinib Maintenance After Allogeneic Hematopoietic Cell Transplantation in FLT3-Mutated AML?
7天前
已关闭
How Could We Further Improve the Gilteritinib Maintenance After Allogeneic Hematopoietic Cell Transplantation in FLT3-Mutated AML?
7天前
已关闭
Managing the unmanageable: evidence-driven approaches to real-world patient prototypes of TP53-mutant myelodysplastic neoplasms and acute myeloid leukemia
9天前
已完结
A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia
21天前
已完结
皖公网安备34019202002308
